Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Grifols, S.A.

GIKLYPNK
Healthcare
Drug Manufacturers - General
$6.45
$0.00(0.00%)
U.S. Market opens in 8h 19m

Grifols, S.A. (GIKLY) Stock Overview

Explore Grifols, S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap17B
P/E Ratio19.97
EPS (TTM)$0.32
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$6.70
3 Months$6.92
1 Year Target$7.07

GIKLY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Grifols, S.A. (GIKLY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.07.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.97 and a market capitalization of 17B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-4.30%
1-Month Change
4.71%
3-Month Change
4.71%
6-Month Change
-13.89%
Year-to-Date (YTD) Change
4.71%
1-Year Change
30.83%
3-Year Change
-0.92%
5-Year Change
-54.61%
All-Time (Max) Change
63.29%

Contact Information

34 93 571 02 21
Avinguda de la Generalitat, 152, Barcelona, 08174

Company Facts

23,833 Employees
IPO DateJan 20, 2010
CountryES
Actively Trading

Frequently Asked Questions